Managing anemia in lymphoma and multiple myeloma
Gunnar BirgegårdDepartment of Haematology, University Hospital, Uppsala, SwedenAbstract: Anemia is common in cancer, and lymphoproliferative disease is no exception. Erythropoiesis-stimulating agents (ESA) have been used for renal anemia since 1986, and considerably later in cancer anemia....
Saved in:
Main Author: | Gunnar Birgegård (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2008-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bispecific antibodies for non-Hodgkin's lymphomas and multiple myeloma
by: Omar Castaneda-Puglianini, et al.
Published: (2021) -
Concomitant occurrence of multiple myeloma with diffuse large B-cell lymphoma
by: Subhashis Mitra, et al.
Published: (2016) -
Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
by: Harvey RD
Published: (2014) -
Multiple Myeloma
Published: (2021) -
Surgical Management of Multiple Myeloma and Plasmocytoma of the Spine
by: G Evangelisti, et al.
Published: (2020)